To date, integrins α2β1, α6β1, α6β4, αVβ3 and β1 have each been shown to promote YAP/TAZ activity in cancer cells to drive proliferation, tumor formation, or tumor growth [245,248,251,280,281,284,287]. This evidence concerns the gene YAP1 and cancer.